Sep 2022 Articles

Articles
Impact of variants of uncertain significance of LDL receptor on phenotypes of familial hypercholesterolemia
Tada H, Kojima N, Yamagami K, et al.
Journal:
J Clin Lipidol

First published: September 30, 2022 DOI: 10.1016/j.jacl.2022.09.007
View
- Share
Articles
Projected Impact of Treatment Intensification with Satin, Ezetimibe, and Statin plus Ezetimibe Fixed-Dose Combination on MACE Across Six Countries
Farnier M, Santos RD, Cosin-Sales J, et al.
Journal:
Eur J Prev Cardiol

First published: September 22, 2022 DOI: 10.1093/eurjpc/zwac214
View
- Share
Articles
Early identification and treatment of women’s cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers
Ivey SL, Hanley HR, Taylor C, et al.
Journal:
Clin Cardiol

First published: September 20, 2022 DOI: 10.1002/clc.23921
View
- Share
Articles
Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA)
Chevli PA, Islam T, Pokharel Y, et al.
Journal:
J Clin Lipidol

First published: September 19, 2022 DOI: 10.1016/j.jacl.2022.09.005
View
- Share
Articles
Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD)
Shaik A, Kosiborod M, de Lemos JA, et al.
Journal:
Clin Cardiol

First published: September 19, 2022 DOI: 10.1002/clc.23923
View
- Share
Articles
Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials
Patti G, Spinoni EG, Grisafi L, et al.
Journal:
Eur Heart J Cardiovasc Pharmacother

First published: September 14, 2022 DOI: 10.1093/ehjcvp/pvac049
View
- Share
Articles
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association
Warden BA, Guyton JR, Kovacs AC, et al.
Journal:
J Clin Lipidol

First published: September 11, 2022 DOI: 10.1016/j.jacl.2022.09.001
View
- Share
Articles
Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis
Kuan PX, Chan WK, Fern Ying DK, et al.
Journal:
Lancet Digit Health

First published: September 1, 2022 DOI: 10.1016/S2589-7500(22)00124-8
View
- Share

Sep 2022 Articles

Articles

Impact of variants of uncertain significance of LDL receptor on phenotypes of familial hypercholesterolemia

Tada H, Kojima N, Yamagami K, et al.

Articles

Projected Impact of Treatment Intensification with Satin, Ezetimibe, and Statin plus Ezetimibe Fixed-Dose Combination on MACE Across Six Countries

Farnier M, Santos RD, Cosin-Sales J, et al.

Articles

Early identification and treatment of women’s cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers

Ivey SL, Hanley HR, Taylor C, et al.

Articles

Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA)

Chevli PA, Islam T, Pokharel Y, et al.

Articles

Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD)

Shaik A, Kosiborod M, de Lemos JA, et al.

Articles

Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials

Patti G, Spinoni EG, Grisafi L, et al.

Articles

Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association

Warden BA, Guyton JR, Kovacs AC, et al.

Articles

Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis

Kuan PX, Chan WK, Fern Ying DK, et al.

Articles

Impact of variants of uncertain significance of LDL receptor on phenotypes of familial hypercholesterolemia

Tada H, Kojima N, Yamagami K, et al.

Share

Articles

Projected Impact of Treatment Intensification with Satin, Ezetimibe, and Statin plus Ezetimibe Fixed-Dose Combination on MACE Across Six Countries

Farnier M, Santos RD, Cosin-Sales J, et al.

Share

Articles

Early identification and treatment of women’s cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers

Ivey SL, Hanley HR, Taylor C, et al.

Share

Articles

Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA)

Chevli PA, Islam T, Pokharel Y, et al.

Share

Articles

Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD)

Shaik A, Kosiborod M, de Lemos JA, et al.

Share

Articles

Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials

Patti G, Spinoni EG, Grisafi L, et al.

Share

Articles

Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association

Warden BA, Guyton JR, Kovacs AC, et al.

Share

Articles

Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis

Kuan PX, Chan WK, Fern Ying DK, et al.

Share